High-Field in vivo Visualization of the Human Globus Pallidus Using 7T MRI

Similar documents
SUPPLEMENTAL DIGITAL CONTENT

Surgical Treatment for Movement Disorders

Deep Brain Stimulation: Patient selection

Deep Brain Stimulation for Parkinson s Disease & Essential Tremor

Deep Brain Stimulation Surgery for Parkinson s Disease

Deep Brain Stimulation: Indications and Ethical Applications

symptoms of Parkinson s disease EXCEPT.

PACEMAKERS ARE NOT JUST FOR THE HEART! Ab Siadati MD

EMERGING TREATMENTS FOR PARKINSON S DISEASE

Parkinson disease: Parkinson Disease

Why high-field MRI? Benefits of high-field MRI. Signal-to-noise ratio (SNR) Contrast (anatomical & functional) 8 x 8 x 8 mm 3 4 x 4 x 4 mm 3

Surgical Treatment of Movement Disorders. Surgical Treatment of Movement Disorders. New Techniques: Procedure is safer and better

Anatomy of the basal ganglia. Dana Cohen Gonda Brain Research Center, room 410

COGNITIVE SCIENCE 107A. Motor Systems: Basal Ganglia. Jaime A. Pineda, Ph.D.

GBME graduate course. Chapter 43. The Basal Ganglia

VL VA BASAL GANGLIA. FUNCTIONAl COMPONENTS. Function Component Deficits Start/initiation Basal Ganglia Spontan movements

Making Things Happen 2: Motor Disorders

10/13/2017. Disclosures. Deep Brain Stimulation in the Treatment of Movement Disorders. Deep Brain Stimulation: Objectives.

Deep Brain Stimulation and Movement Disorders

Basal ganglia Sujata Sofat, class of 2009

Basal ganglia motor circuit

As clinical experience with deep-brain stimulation (DBS) of

The motor regulator. 1) Basal ganglia/nucleus

DEEP BRAIN STIMULATION

Basal Ganglia. Steven McLoon Department of Neuroscience University of Minnesota

Parkinson s Disease Webcast January 31, 2008 Jill Ostrem, M.D. What is Parkinson s Disease?

Punit Agrawal, DO Clinical Assistant Professor of Neurology Division of Movement Disorders OSU Department of Neurology

Basal Ganglia. Introduction. Basal Ganglia at a Glance. Role of the BG

Surgical Treatment: Patient Edition

Damage on one side.. (Notes) Just remember: Unilateral damage to basal ganglia causes contralateral symptoms.

See Policy CPT/HCPCS CODE section below for any prior authorization requirements

Shaheen Shaikh, M.D. Assistant Professor of Anesthesiology, University of Massachusetts Medical center, Worcester, MA.

Validation of basal ganglia segmentation on a 3T MRI template

Visualization and Quantification of the Striato pallidonigral Fibers in Parkinson's Disease Using Diffusion Tensor Imaging

Deep Brain Stimulation. Is It Right for You?

Deep Brain Stimulation: Surgical Process

2017 OPTIONS FOR INDIVIDUAL MEASURES: REGISTRY ONLY. MEASURE TYPE: Process

Lecture XIII. Brain Diseases I - Parkinsonism! Brain Diseases I!

BASAL GANGLIA: A "pit stop" that integrates the movement, cognition and emotion.

The webinar will begin momentarily. Tractography-based Targeting for Functional Neurosurgery

Imaging alone versus microelectrode recording guided targeting of the STN in patients with Parkinson s disease

THE EFFECTS OF SUBTHALAMIC NUCLEUS DEEP BRAIN STIMULATION ON VOCAL TRACT DYNAMICS IN PARKINSON S DISEASE

Subthalamic Nucleus Deep Brain Stimulation (STN-DBS)

DBS efficacia, complicanze in cronico e nuovi orizzonti terapeutici

modulation of multiple brain networks.

Basal Ganglia George R. Leichnetz, Ph.D.

Deep Brain Stimulation For Parkinson s Disease

Troubleshooting algorithms for common DBS related problems in tremor and dystonia

MRI-guided STN DBS in Parkinson s disease without microelectrode recording: efficacy and safety

LBA 01 Progressive Relaxation Trainning in Parkinson s Patients as a Way to Manage Levodopa Induced DyskinesiaA. Aguilar, J. Herruzo (Cordoba, Spain)

Neurodegenerative Disease. April 12, Cunningham. Department of Neurosciences

Teach-SHEET Basal Ganglia

Functional Neuroanatomy and Physiology for Movement Disorders

Outcomes following deep brain stimulation lead revision or reimplantation for Parkinson s disease

Transcranial sonography in movement disorders

Deep brain stimulation (DBS) has been

Temporal patterning of neural synchrony in the basal ganglia in Parkinson s disease

Basal Ganglia. Today s lecture is about Basal Ganglia and it covers:

A. General features of the basal ganglia, one of our 3 major motor control centers:

Pallidal Deep Brain Stimulation

A. General features of the basal ganglia, one of our 3 major motor control centers:

Intraoperative microelectrode recording (MER) for targeting during deep brain stimulation (DBS) procedures 巴黎第六大学医学院生理学

Data Mining Tools used in Deep Brain Stimulation Analysis Results

Introduction. Case. Case Report. Jin-gyu Choi 1, Si-hoon Lee 2, Young-Min Shon 2,3, Byung-chul Son 1,3

10/3/2016. T1 Anatomical structures are clearly identified, white matter (which has a high fat content) appears bright.

DISORDERS OF THE MOTOR SYSTEM. Jeanette J. Norden, Ph.D. Professor Emerita Vanderbilt University School of Medicine

WHAT DEFINES YOPD? HANDLING UNIQUE CONCERNS REBECCA GILBERT, MD, PHD VICE PRESIDENT, CHIEF SCIENTIFIC OFFICER, APDA MARCH 14, 2019

An Automated Method for Neuronal Spike Source Identification

Deep Brain stimulation for cognitive disorders: Insights on targeting Nucleus basalis of Meynert in Alzheimer s dementia

ASSFN Clinical Case: Bilateral STN DBS Implant for Parkinson s Disease

NIH Public Access Author Manuscript Proc SPIE. Author manuscript; available in PMC 2014 February 07.

For more information about how to cite these materials visit

ORIGINAL CONTRIBUTION. Improvement in Parkinson Disease by Subthalamic Nucleus Stimulation Based on Electrode Placement

Movement Disorders Will Garrett, M.D Assistant Professor of Neurology

Neuroimaging and Neurostimulation: Going inside the black box

Neuroimaging for Diagnosis of Psychiatric Disorders

Functional Distinctions

Efficient Feature Extraction and Classification Methods in Neural Interfaces

CN V! touch! pain! Touch! P/T!

BASAL GANGLIA. Dr JAMILA EL MEDANY

Biological Bases of Behavior. 8: Control of Movement

The Wonders of the Basal Ganglia

P rimary generalised dystonia (PGD) is a movement disorder

Parkinsonism or Parkinson s Disease I. Symptoms: Main disorder of movement. Named after, an English physician who described the then known, in 1817.

1/2/2019. Basal Ganglia & Cerebellum a quick overview. Outcomes you want to accomplish. MHD-Neuroanatomy Neuroscience Block. Basal ganglia review

Patient selection for surgery: Parkinson s disease

Visualization strategies for major white matter tracts identified by diffusion tensor imaging for intraoperative use

Epilepsy & Functional Neurosurgery

Linköping University Post Print. Patient-specific models and simulations of deep brain stimulation for postoperative follow-up

A3.1.7 Motor Control. 10 November 2016 Institute of Psychiatry,Psychology and Neuroscience Marinela Vavla

The possibility of deep brain stimulation to treat eating disorders.

Deep Brain Stimulation for Movement Disorders

DBS Programming. Paul S Fishman MD, PhD University of Maryland School of Medicine PFNCA 3/24/18

Connections of basal ganglia

Functional Role of the Basal Ganglia in the Planning and Execution of Actions

MRI Study of Caudate Nucleus Volume and Its Cognitive Correlates in Neuroleptic-Naive Patients With Schizotypal Personality Disorder

Deep Brain Stimulation for Movement Disorders

HealthTalks. Deep Brain Stimulation for Parkinson s Disease Patients

Palladotomy and Pallidal Deep Brain Stimulation

Evaluation and Management of Parkinson s Disease in the Older Patient

Transcription:

Niederer 1 High-Field in vivo Visualization of the Human Globus Pallidus Using 7T MRI Abstract In the past several decades the introduction of high-resolution, three-dimensional modeling techniques have revolutionized our ability to visualize the human brain and its connectivity patterns between structures. The use of highfield magnetic resonance imaging (MRI) offers promising applications in advancing therapeutic compared to STN DBS. Furthermore, the GPi is also less susceptible to damage following insertion of the DBS lead compared to the smaller STN target, which likely has a large role in cognitive dysfunction post-dbs. 3 Thus GPi DBS may be a safer strategy for therapeutic treatment of patients with moderate-to-advanced Parkinson disease. strategies for a wide range of neurodegenerative diseases. Deep brain stimulation (DBS) surgery is one such strategy used in the treatment of patients with neurological movement disorders such as Parkinson disease (PD), essential tremor, and dystonia, involving the degeneration of basal Introduction The globus pallidus is structurally divided into two parts, the globus pallidus interna (GPi) and the globus pallidus externa (GPe), which are separated by a thin layer termed the lamina ganglia circuits. 1 pallidi medialis. For patients with Parkinson For patients with moderate-toadvanced Parkinson disease, in which drug therapy is no longer sufficient, the globus pallidus interna (GPi) and subthalamic nucleus (STN) are targets for DBS 2, however, there has been debate on whether unilateral GPi or STN DBS is more effective as a therapeutic strategy for patients with moderate-to-advanced Parkinson disease. Recent research suggests that stimulation of GPi in DBS is a better therapeutic approach as the GPi is a much larger structure and does not require the same degree of precision for placement of DBS lead as disease, the GPi is a target for DBS surgery. Most DBS surgeries still heavily rely on atlases constructed from post-mortem specimens that are superimposed on a patient s MRI scan, an indirect-targeting method still prevalent to this date. Patient-specific, three-dimensional mapping of structures within the basal ganglia core through the use of high-field magnetic resonance imaging may prove to be a valuable pre-operative tool in providing important information for the planning of DBS surgery and targeting specific structures.

Niederer 2 Due to the variability in the location of basal ganglia nuclei among human subjects and small target structures which generally measure less than 10 mm in most dimensions4 for the placement of DBS electrodes, comprehensive patient-specific mapping of the globus pallidus using high-field MRI scans of individuals could provide surgeons with significant pre-operative information for DBS surgery planning.5,6 Patient-specific visualization of the globus pallidus could provide higher success rates for DBS procedures as the success of such surgical - Figure 1 Axial cross-section of adult brain specifying location of the globus pallidus procedures are heavily dependent on the accurate placement of DBS electrodes into the target applications of comprehensive patient-specific region of the brain. Reducing the need for mapping of the globus pallidus can be validated. multiple microelectrode recording (MER) The research question addressed in this study penetrations during GPi DBS surgery, detailed was whether gender-specific volumetric mapping of the globus pallidus could also serve differences exist in the globus pallidus in to minimize the procedural risk of intracranial patients with moderate-to-advanced Parkinson hemorrhage and damage to axonal tracts.4 disease. It is known that the overall head size of Furthermore, patient-specific information could males are typically larger than that of a female, have a significant impact on the outcome of a however, subcortical structures seem to have much greater number of DBS treatments as the similar sizes. Based on this knowledge it was indications for DBS surgeries are expected to hypothesized that there would be no evidence of increase significantly in the near future.6 volumetric differences in the globus pallidus By visualizing the globus pallidus in vivo using high-field 7-Tesla MRI scans with T2 contrast of individual human subjects, the procedural between male and female patients with Parkinson disease.

Niederer 3 Materials and Methods To investigate whether volumetric differences exist between male and female patients with moderate-to-advanced Parkinson disease, the three-dimensional software platform Avizo (FEI Software, Hillsboro, Oregon) was used for the visualization, manipulation, and analysis of patient data. Using the program, segmentations of the GPi and GPe borders of 50 patients with moderate-to-advanced Parkinson disease were completed to construct three-dimensional patient-specific representations of the globus pallidus used for quantitative volumetric analysis. Refer to Figure 2 for a representation of an axial section of the globus pallidus segmented in Avizo, in which GPi has been labeled green and GPe has been labeled red. Following the segmentation of each axial slice of the globus pallidus, a three-dimensional patientspecific representation of the structure could be generated, from which volumes for GPi and GPe could be determined and used for statistical analysis. Refer to Figure 3 for a threedimensional patient-specific surface view of the globus pallidus generated from axial segmentations of GPi and GPe borders. - Figure 2 Defining the border of bilateral globus pallidus with label field editing Avizo software

Niederer 4 - Figure 3 Three- dimensional visualization of bilateral globus pallidus in Project View of Avizo Results From the segmentation data bilateral GPi and GPe volumes were extracted from Avizo and used to calculate the average volumes and standard deviations for each data set. GPi_L (left) average volume for all patients was found to be 529 mm 3 (SD = 122 mm 3 ), as compared to an average volume of 575 mm 3 (SD = 125 mm 3 ) for GPi_R (right). Average volumes for GPe_L and GPe_R were found to be 888 mm 3 (SD = 197 mm 3 ) and 885 mm 3 (SD = 175 mm 3 ), respectively. Average total volume for globus pallidus was found to be 2,876.97 mm 3 with a standard deviation of 466.52 mm 3. This value for total globus pallidus volume was larger than literature values for globus pallidus volume of control subjects, which are given in Table 1. tric analysis of GPi and GPe is still a relatively new area of research with the advent of high-field magnetic resonance imaging techniques that allow for increased resolution and identification of structural landmarks. A two-tailed two-sample t-test was used to determine whether a significant difference in GPi volume exists between male and female subjects. In this test, volumetric data for 11 female

Niederer 5 Source Total GP_L Total GP_R Total GPi Total GPe Total GP 7T Patient Data 1417.09 1459.88 1104.23 1772.74 2876.97 Spinks, et al. 7 Not Measured Not Measured 1180 2490 3660* Hokama, et al. 8 1150 1110 Not Measured Not Measured 2260 Peterson, et al. 9 Not Measured Not Measured Not Measured Not Measured 1762.3 Hopkins, et al. 10 Not Measured Not Measured Not Measured Not Measured 2340 Harris, et al. 11 Not Measured Not Measured Not Measured Not Measured 2060 - Table 1 Average volumes for all subjects in the 7T DBS patient data set were measured and compared with literature volumes for globus pallidus (all volumes reported in mm 3 ) *The reported volume of 3,660 mm 3 for total globus pallidus was regarded as an outlier - Figure 4 Summary of gender-specific, age-specific, and bilateral volumetric differences in GPi (error bars represent the standard error for each data set)

Niederer 6 subjects were compared with data for 36 male subjects. Three subjects from the patient data set did not have a specified gender and were excluded from the sample t-test. In order to compare independent groups of unequal sample size, the Satterthwaite approximate was used to determine the degrees of freedom (df) needed to calculate the probability value (p-value). The results of the t-test confirmed the null hypothesis that no significant gender-specific volumetric differences in GPi exist in patients with moderate-to-advanced Parkinson disease. Large p-values (p > 0.5) were observed for unilateral GPi differences between genders, indicating that volumetric differences observed in the sample of male and female patients were statistically insignificant (p = 0.863, df = 16 for GPi_L and p = 0.643, df = 16 for GPi_R). In addition to testing for gender-specific differences in volume, another two-sample t-test was performed to test for age-related volumetric differences in the GPi. Subjects were divided into one of two groups, the first consisting of 28 patients younger than 65 years and the second consisting of 19 patients 65 years and older. The same three patients excluded from the genderspecific t-test were excluded from the agespecific t-test due to unspecified age. Again, the Satterthwaite approximate was used to determine degrees of freedom for the two groups. Although much smaller p-values were observed, the results of the t-test indicated that no significant age-specific differences in unilateral GPi volumes exist between the two groups tested (p = 0.297, df = 38 for GPi_L and p = 0.112, df = 35 for GPi_R). A statistical significance level of 0.05 (p < 0.05) is generally needed to infer statistical significance for a given set of data. Although it was concluded that there was no statistical evidence to indicate gender or agespecific differences in GPi volume, a paired t- test comparing GPi_L and GPi_R for all patients yielded an unexpected result. The mean volume of GPi_L for all patients was 529 mm 3 (SD = 122 mm 3 ), whereas the mean volume of GPi_R for all patients was 575 mm 3 (SD = 125 mm 3 ). Thus, GPi_R was determined to be an average of 8.70% larger than GPi_L. To test whether this observation was statistically significant, a onetailed paired t-test was performed to determine if GPi_R is significantly larger in volume than GPi_L in patients with moderate-to-advanced Parkinson disease. The t-test yielded a very low p-value (p < 0.01) indicating, for the patient data set tested, GPi_R volume was significantly larger than GPi_L volume

Niederer 7 (p = 0.00415, df = 49). This finding was not replicated for GPe, in which another paired t-test (one-tailed) was performed yielding a much larger p-values (p = 0.439, df = 49). It was determined that differences in bilateral GPe were statistically insignificant. A final one-tailed paired t-test was performed to determine whether whole GP_R was significantly larger in volume than whole GP_L. Although whole GP_R was observed to be an average of 3.02% larger in volume than whole GP_L from the patient data set, this difference was determined to be statistically insignificant (p = 0.0674, df = 49). Refer to Figure 4 for a summary of genderspecific, age-specific, and bilateral volumetric differences of GPi in patients with moderate-toadvanced Parkinson disease. was no evidence of any age-specific differences in GPi volume when comparing patients younger than 65 years to patients 65 years and older. A possible explanation for the larger volumes observed from the Avizo segmentations using high-field 7T patient data as compared with referenced literature volumes in Table 1 is a phenomenon known as the partial volume effect. Partial volume effect can be described as the limited ability to clearly identify anatomical borders due to low resolution. Today s 1.5 Tesla MRI machines used in clinical settings generate patient data with a greater space between axial slices, compared with patient data obtained at 7 Tesla (2-3 mm in 1.5 T compared to 1 mm in 7T). This difference may result in the apparent loss of volume in brain structures imaged at Discussion Following statistical analysis of measured GPi volumes in patients with moderate-to-advanced Parkinson disease, it was determined that there was no evidence to support any gender-specific volumetric differences in the globus pallidus. This finding was consistent with previous knowledge that subcortical structures appear to have similar sizes despite differences in average head size between genders. In addition, there lower magnetic fields. The advantage that highfield magnetic resonance imaging provides is increased resolution and greater contrast of structural borders. This allows for the improved ability of defining structures in the brain and generating accurate three-dimensional representations. The finding that GPi_R was significantly larger in volume than GPi_L from the data set of patients with Parkinson disease may have numerous procedural applications, providing

Niederer 8 statistical power of the patient data in this study would help to validate the finding that GPi_R is indeed larger in volume than GPi_L in patients with moderate-to-advanced Parkinson disease. surgeons with valuable pre-operative information useful for DBS surgery planning. Knowledge of volumetric differences between GPi_L and GPi_R prior to surgery could impact the preoperative planning for the placement of DBS lead in the GPi structure. In addition, taking into account patient-specific information prior to surgery could help to improve the success rate of DBS operations. Although it was statistically determined that GPi_R was significantly larger in volume than GPi_L for the patient data set, it is important to note that there was also a significant amount of variance in measured patient GPi volumes. This variance can be quantified by Cohen s d size effect. A Cohen s d size effect greater than 0.5 is generally used to infer that the statistical power of a data set is moderate, whereas a size effect greater than 0.8 is used to infer strong statistical power. The size effect for the patient Conclusion This work helps to define the volumetric differences of the globus pallidus in patients with moderate-to-advanced Parkinson disease. Although there is no evidence of gender or agespecific differences in globus pallidus volume, there is significant evidence to suggest that GPi_R is larger in volume than GPi_L in patients with Parkinson disease. The potential causes for this difference are still unclear and is a future avenue of research. Further research is needed to replicate these findings and confirm the validity of apparent volumetric differences in bilateral GPi in patients with moderate-to-advanced Parkinson disease. data set was calculated to be 0.425, indicating that the statistical power of the data could be improved. The lower the size effect, the more likely observed findings may be erroneous and attributable to chance. One approach to improving the size effect would be to analyze a larger sample of patient data to lower the variance in measured volumes. Improving the

Niederer 9 References: 1 The Journal of the American Medical Association. Bilateral Deep Brain Stimulation vs Best Medical Therapy for Patients With Advanced Parkinson Disease. The JAMA Network. 2009; 301(1). 2 The National Collaborating Centre for Chronic Conditions, ed. Surgery for Parkinson s disease. Parkinson's Disease. London: Royal College of Physicians. 2006; 101 11. ISBN 1-86016-283-5. 3- Okun M, Fernandez H, Wu S, et al. Cognition and Mood in Parkinson Disease in STN versus GPi DBS: The COMPARE Trial. 2010 May 1; 65(5); 586-595. PubMed. PMCID: PMC2692580. 4 Ben-Haim S, Asaad WF, Gale JT, Eskandar EN. Risk factors for hemorrhage during microelectrodeguided deep brain stimulation and the introduction of an improved microelectrode design. Neurosurgery. 2009;64(4):754-762. 5 Ashkan K, Blomstedt P, Zrinzo L, et al. Variability of the subthalamic nucleus: the case for direct MRI guided targeting. Br J Neurosurg. 2007;21(2):197-200. 6 Richter EO, Hoque T, Halliday W, Lozano AM, Saint-Cyr JA. Determining the position and size of the subthalamic nucleus based on magnetic resonance imaging results in patients with advanced Parkinson disease. J Neurosurg. 2004;100(3): 541-546. 7 Spinks R, Nopoulos P, Ward J, Fuller R, Magnotta V, Andreasen N. Globus pallidus volume is related to symptom severity in neuroleptic naive patients with schizophrenia. Schizophrenia Research. 2005; 73 (2): 229-233. 8 Hokama H, Shenton M, Nestor P, Kikinis R, Levitt J, Metcalf D, Wible C, O Donnell B, Jolesz F, McCarley R. Caudate, putamen, and globus pallidus volume in schizophrenia: A quantitative MRI study. Psychiatry Research: Neuroimaging. 1995; 61: 209-229. 9 Peterson B, Prakash T, Kane M, Scahill L, Zhang H, Bronen R, King R, Leckman J, Staib L. Basal Ganglia s in Patients With Gilles de la Tourette Syndrome. The JAMA Network. 2003; 60 (4). 10 Hopkins R, Fearing M, Weaver L. Basal ganglia lesions following carbon monoxide poisoning. 2006; 20 (3); 273-281. 11 Harris G, Codori AM, Lewis R, Schmidt E, Bedi A, Brandt J. Reduced basal ganglia blood flow and volume in pre-symptomatic, gene-tested persons at-risk for Huntington s disease. Brain: A Journal of Neurology. 1999; 122 (9); 1667-1678.